Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00600665 · ClinicalTrials.gov registry record · NA
Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease
A NA study of Anemia, Sickle Cell and Hemoglobin SC Disease, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 279
- Enrollment target
- 1
- Study location
NCT00600665: Completed NA study of Anemia, Sickle Cell and Hemoglobin SC Disease, sponsored by University of Illinois at Chicago.
NCT00600665 is a NA study of Anemia, Sickle Cell and Hemoglobin SC Disease that has completed, run by University of Illinois at Chicago. The registered enrollment target is 279 participants, above the 102-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (174% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00600665, a NA study of Anemia, Sickle Cell and Hemoglobin SC Disease, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 279 participants
- Enrollment target
- 1
- Study location
Study Summary
Sickle cell disease (SCD) is a blood disorder that is characterized by intense, painful episodes known as sickle cell crises. This study will evaluate the effectiveness of PAINRelieveIt, a three-part computer-based pain management tool, in treating adults with SCD.
Primary Outcome
Range 0-5. Higher score indicates more perceived barriers (greater concern about pain management beliefs and/or analgesic side effects)
Conditions Studied
Interventions
- BEHAVIORAL PAINReportIt
- BEHAVIORAL PAINUCope
- BEHAVIORAL PAINConsultN
Study Locations (1)
Illinois
- University of Illinois at Chicago Sickle Cell Center and Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 279 participants |
| Start Date | 2007-02 |
| Est. Completion | 2014-06 |
| Phase | NA |
What the finished NCT00600665 record still lists
NCT00600665 is an interventional study that assigns participants to a tested intervention. The registered 279 participants enrollment target is mid-sized for trials with a published cap, above the 102-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (174% higher).
The record links to 2 conditions, with Anemia, Sickle Cell appearing as the primary indexed condition, and to 3 interventions - of which PAINReportIt is the first listed.
NCT00600665 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00600665 about?
NCT00600665 is a clinical study titled "Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease". Sickle cell disease (SCD) is a blood disorder that is characterized by intense, painful episodes known as sickle cell crises. This study will evaluate the effectiveness of PAINRelieveIt, a three-part computer-based pain management tool, in treating adults with SCD.
What is the current status of trial NCT00600665?
This trial is currently completed. It is a NA study. The enrollment target is 279 participants. The study started on 2007-02. Estimated completion is 2014-06.
What conditions does trial NCT00600665 study?
This clinical trial studies the following conditions: Anemia, Sickle Cell, Hemoglobin SC Disease.
What interventions are being tested in trial NCT00600665?
The interventions under investigation include: PAINReportIt (BEHAVIORAL), PAINUCope (BEHAVIORAL), PAINConsultN (BEHAVIORAL).
Who is sponsoring clinical trial NCT00600665?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00600665 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia, Sickle Cell
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00600665's enrollment target sits among peer trials
279 2nd of 17 higher than 15 of 17 other Anemia, Sickle Cell trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia, Sickle Cell trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic and Hemodynamic Reserve in Pediatric SCA
RECRUITING · NA
-
Therapeutic Response Evaluation and Adherence Trial (TREAT)
ACTIVE NOT RECRUITING · NA
-
Telemedicine for Children With Sickle Cell Disease
ACTIVE NOT RECRUITING · NA
-
Feasibility and Efficacy of a Home-based, Computerized Cognitive Training Program in Pediatric Sickle Cell Disease
COMPLETED · NA
-
Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease
COMPLETED · NA
-
MBSR for Pain Catastrophizing in SCD
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04783857 · 279 participants · Phase 4
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
- NCT05407324 · 279 participants · Phase 2
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
- NCT06299748 · 279 participants
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
- NCT06582784 · 279 participants · NA
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia